Altamira Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference September 9-11
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 03 2024
0mins
Source: Newsfilter
Company Presentation Announcement: Altamira Therapeutics' CEO Thomas Meyer will present at the H.C. Wainwright 26th Annual Global Investment Conference from September 9-11, 2024, with an on-demand presentation available starting September 9 at 7:00 am ET.
Company Overview: Altamira Therapeutics focuses on RNA delivery technology for non-liver targets and is developing two siRNA programs for cancer and rheumatoid arthritis, while also holding a stake in Altamira Medica AG and exploring partnerships for its legacy assets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
